Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium ulcerans | DNA polymerase IV | 0.004 | 0.0434 | 0.4752 |
Mycobacterium ulcerans | NADPH:adrenodoxin oxidoreductase FprB | 0.0019 | 0.0099 | 0.1083 |
Giardia lamblia | Thioredoxin reductase | 0.0019 | 0.0099 | 0.1083 |
Schistosoma mansoni | glutamate synthase | 0.0019 | 0.0099 | 0.0099 |
Echinococcus multilocularis | smad | 0.0018 | 0.0093 | 0.0081 |
Mycobacterium tuberculosis | Probable NADH dehydrogenase Ndh | 0.0464 | 0.7097 | 0.8962 |
Brugia malayi | Thioredoxin reductase | 0.0203 | 0.3002 | 0.7435 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.007 | 0.0913 | 0.304 |
Trypanosoma cruzi | 2,4-dienoyl-coa reductase fadh1, putative | 0.0019 | 0.0099 | 0.0329 |
Plasmodium falciparum | lysine-specific histone demethylase 1, putative | 0.0017 | 0.007 | 0.0232 |
Loa Loa (eye worm) | hypothetical protein | 0.009 | 0.1218 | 0.3016 |
Mycobacterium tuberculosis | Probable reductase | 0.0464 | 0.7097 | 0.8962 |
Echinococcus granulosus | smad | 0.0018 | 0.0093 | 0.0081 |
Toxoplasma gondii | pyruvate dehydrogenase complex subunit PDH-E3II | 0.007 | 0.0913 | 0.304 |
Mycobacterium ulcerans | NADPH:adrenodoxin oxidoreductase FprA | 0.0019 | 0.0099 | 0.1083 |
Leishmania major | NADH dehydrogenase, putative | 0.0019 | 0.0099 | 0.0329 |
Trypanosoma brucei | hypothetical protein, conserved | 0.0019 | 0.0099 | 0.0329 |
Trypanosoma brucei | NADH dehydrogenase | 0.0019 | 0.0099 | 0.0329 |
Trypanosoma cruzi | dihydrolipoyl dehydrogenase, putative | 0.007 | 0.0913 | 0.304 |
Echinococcus granulosus | flap endonuclease 1 | 0.0029 | 0.0257 | 0.0639 |
Trypanosoma brucei | NADPH:adrenodoxin oxidoreductase, mitochondrial, putative | 0.0019 | 0.0099 | 0.0329 |
Plasmodium vivax | lysine-specific histone demethylase 1, putative | 0.0017 | 0.007 | 0.0232 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.004 | 0.0434 | 0.1445 |
Mycobacterium leprae | Probable NADH-dependent glutamate synthase (small subunit) GltD (L-glutamate synthase) (L-glutamate synthetase) (NADH-glutamate | 0.0019 | 0.0099 | 0.0037 |
Schistosoma mansoni | rab geranylgeranyl transferase alpha subunit | 0.004 | 0.0434 | 0.0434 |
Schistosoma mansoni | dihydrolipoamide dehydrogenase | 0.007 | 0.0913 | 0.0913 |
Trypanosoma brucei | trypanothione reductase | 0.0203 | 0.3002 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0083 | 0.1108 | 0.2743 |
Echinococcus granulosus | Smad4 | 0.0018 | 0.0093 | 0.0081 |
Echinococcus granulosus | apoptosis inducing factor 1 mitochondrial | 0.0019 | 0.0099 | 0.01 |
Loa Loa (eye worm) | Smad1 | 0.0018 | 0.0093 | 0.0231 |
Trypanosoma cruzi | trypanothione reductase, putative | 0.0203 | 0.3002 | 1 |
Mycobacterium ulcerans | flavoprotein disulfide reductase | 0.007 | 0.0913 | 1 |
Trichomonas vaginalis | DNA polymerase IV / kappa, putative | 0.004 | 0.0434 | 0.4115 |
Plasmodium falciparum | glutathione reductase | 0.007 | 0.0913 | 0.304 |
Mycobacterium leprae | PROBABLE NADH DEHYDROGENASE NDH | 0.0464 | 0.7097 | 0.8962 |
Mycobacterium ulcerans | NADPH:adrenodoxin oxidoreductase FprA | 0.0019 | 0.0099 | 0.1083 |
Mycobacterium leprae | Probable NADPH:adrenodoxin oxidoreductase FprA (NADPH-FERREDOXIN REDUCTASE) | 0.0019 | 0.0099 | 0.0037 |
Leishmania major | DNA polymerase kappa, putative,DNA polymerase IV, putative | 0.004 | 0.0434 | 0.1445 |
Mycobacterium tuberculosis | Dihydrolipoamide dehydrogenase LpdC (lipoamide reductase (NADH)) (lipoyl dehydrogenase) (dihydrolipoyl dehydrogenase) (diaphoras | 0.0515 | 0.7911 | 1 |
Mycobacterium tuberculosis | Possible dehydrogenase/reductase | 0.0019 | 0.0099 | 0.0037 |
Trypanosoma brucei | DNA polymerase eta, putative | 0.004 | 0.0434 | 0.1445 |
Echinococcus multilocularis | dihydropyrimidine dehydrogenase (NADP+) | 0.0019 | 0.0099 | 0.01 |
Plasmodium vivax | flap endonuclease 1, putative | 0.0029 | 0.0257 | 0.0856 |
Echinococcus granulosus | dihydrolipoamide dehydrogenase | 0.007 | 0.0913 | 0.2875 |
Plasmodium vivax | protoporphyrinogen oxidase, putative | 0.0017 | 0.007 | 0.0232 |
Schistosoma mansoni | TGF-beta signal transducer Smad2 | 0.0018 | 0.0093 | 0.0093 |
Mycobacterium ulcerans | oxidoreductase | 0.0017 | 0.007 | 0.0762 |
Echinococcus granulosus | lysine specific histone demethylase 1A | 0.0083 | 0.1108 | 0.354 |
Brugia malayi | MH2 domain containing protein | 0.0018 | 0.0093 | 0.0231 |
Plasmodium falciparum | conserved Plasmodium protein, unknown function | 0.0017 | 0.007 | 0.0232 |
Leishmania major | flap endonuclease-1 (FEN-1), putative | 0.0029 | 0.0257 | 0.0856 |
Schistosoma mansoni | disulfide oxidoreductase | 0.0019 | 0.0099 | 0.0099 |
Loa Loa (eye worm) | flap endonuclease-1 | 0.0029 | 0.0257 | 0.0636 |
Mycobacterium tuberculosis | Probable dehydrogenase | 0.0464 | 0.7097 | 0.8962 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.004 | 0.0434 | 0.0464 |
Mycobacterium leprae | DIHYDROLIPOAMIDE DEHYDROGENASE LPD (LIPOAMIDE REDUCTASE (NADH)) (LIPOYL DEHYDROGENASE) (DIHYDROLIPOYL DEHYDROGENASE) (DIAPHORASE | 0.0515 | 0.7911 | 1 |
Echinococcus granulosus | thioredoxin glutathione reductase | 0.0203 | 0.3002 | 1 |
Brugia malayi | NADPH:adrenodoxin oxidoreductase, mitochondrial precursor | 0.0019 | 0.0099 | 0.0245 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.004 | 0.0434 | 0.1445 |
Trichomonas vaginalis | DNA polymerase eta, putative | 0.004 | 0.0434 | 0.4115 |
Brugia malayi | hypothetical protein | 0.0017 | 0.007 | 0.0172 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.004 | 0.0434 | 0.1445 |
Brugia malayi | ImpB/MucB/SamB family protein | 0.004 | 0.0434 | 0.1074 |
Mycobacterium leprae | THIOREDOXIN TRXC (TRX) (MPT46) | 0.0019 | 0.0099 | 0.0037 |
Mycobacterium ulcerans | DNA polymerase IV | 0.004 | 0.0434 | 0.4752 |
Brugia malayi | glutathione reductase | 0.0203 | 0.3002 | 0.7435 |
Giardia lamblia | Glutamate synthase | 0.0019 | 0.0099 | 0.1083 |
Echinococcus granulosus | NADPH:adrenodoxin oxidoreductase | 0.0019 | 0.0099 | 0.01 |
Toxoplasma gondii | NADH dehydrogenase (NDH2-II) | 0.0019 | 0.0099 | 0.0329 |
Trypanosoma brucei | 2,4-dienoyl-coa reductase-like protein | 0.0019 | 0.0099 | 0.0329 |
Echinococcus multilocularis | TGF beta signal transducer SmadC | 0.0018 | 0.0093 | 0.0081 |
Toxoplasma gondii | pyridine nucleotide-disulfide oxidoreductase domain-containing protein | 0.0019 | 0.0099 | 0.0329 |
Mycobacterium ulcerans | thioredoxin reductase TrxB2 | 0.0019 | 0.0099 | 0.1083 |
Trypanosoma brucei | dihydrolipoamide dehydrogenase | 0.007 | 0.0913 | 0.304 |
Loa Loa (eye worm) | programmed cell death 8 | 0.0019 | 0.0099 | 0.0245 |
Mycobacterium ulcerans | NADH dehydrogenase Ndh | 0.0019 | 0.0099 | 0.1083 |
Loa Loa (eye worm) | hypothetical protein | 0.0017 | 0.007 | 0.0172 |
Loa Loa (eye worm) | hypothetical protein | 0.0024 | 0.018 | 0.0445 |
Trypanosoma cruzi | flap endonuclease-1 (FEN-1), putative | 0.0029 | 0.0257 | 0.0856 |
Trypanosoma brucei | unspecified product | 0.0028 | 0.0239 | 0.0795 |
Schistosoma mansoni | terminal deoxycytidyl transferase | 0.004 | 0.0434 | 0.0434 |
Trypanosoma brucei | dihydrolipoamide dehydrogenase | 0.007 | 0.0913 | 0.304 |
Brugia malayi | MH2 domain containing protein | 0.0018 | 0.0093 | 0.0231 |
Mycobacterium tuberculosis | Probable thioredoxin reductase TrxB2 (TRXR) (TR) | 0.0019 | 0.0099 | 0.0037 |
Toxoplasma gondii | pyridine nucleotide-disulfide oxidoreductase domain-containing protein | 0.0019 | 0.0099 | 0.0329 |
Toxoplasma gondii | histone lysine-specific demethylase LSD1/BHC110/KDMA1A | 0.0017 | 0.007 | 0.0232 |
Leishmania major | hypothetical protein, conserved | 0.0019 | 0.0099 | 0.0329 |
Brugia malayi | MH2 domain containing protein | 0.0269 | 0.4037 | 1 |
Plasmodium falciparum | thioredoxin reductase | 0.0203 | 0.3002 | 1 |
Brugia malayi | MH1 domain containing protein | 0.0018 | 0.0093 | 0.0231 |
Giardia lamblia | DINP protein human, muc B family | 0.004 | 0.0434 | 0.4752 |
Echinococcus multilocularis | terminal deoxycytidyl transferase rev1 | 0.004 | 0.0434 | 0.1242 |
Echinococcus multilocularis | dna polymerase kappa | 0.004 | 0.0434 | 0.1242 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.004 | 0.0434 | 0.1445 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.004 | 0.0434 | 0.1445 |
Brugia malayi | glutamate synthase | 0.0019 | 0.0099 | 0.0245 |
Schistosoma mansoni | sulfide quinone reductase | 0.0019 | 0.0099 | 0.0099 |
Trypanosoma cruzi | dihydrolipoyl dehydrogenase, putative | 0.007 | 0.0913 | 0.304 |
Echinococcus multilocularis | mothers against decapentaplegic 5 | 0.0018 | 0.0093 | 0.0081 |
Trypanosoma cruzi | 2,4-dienoyl-coa reductase-like protein, putative | 0.0019 | 0.0099 | 0.0329 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.004 | 0.0434 | 0.1445 |
Brugia malayi | Smad1 | 0.0018 | 0.0093 | 0.0231 |
Mycobacterium tuberculosis | Probable NADPH dependent 2,4-dienoyl-CoA reductase FadH (2,4-dienoyl coenzyme A reductase) (4-enoyl-CoA reductase) | 0.0019 | 0.0099 | 0.0037 |
Echinococcus granulosus | dihydropyrimidine dehydrogenase NADP | 0.0019 | 0.0099 | 0.01 |
Plasmodium vivax | dihydrolipoyl dehydrogenase, mitochondrial, putative | 0.007 | 0.0913 | 0.304 |
Echinococcus granulosus | dna polymerase kappa | 0.004 | 0.0434 | 0.1242 |
Trichomonas vaginalis | mercuric reductase, putative | 0.007 | 0.0913 | 1 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.004 | 0.0434 | 0.1445 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.004 | 0.0434 | 0.1445 |
Echinococcus multilocularis | Smad4 | 0.0018 | 0.0093 | 0.0081 |
Plasmodium falciparum | dihydrolipoyl dehydrogenase, mitochondrial | 0.007 | 0.0913 | 0.304 |
Brugia malayi | alpha keto acid dehydrogenase complex, E3 component, lipoamide dehydrogenase | 0.0052 | 0.0619 | 0.1532 |
Toxoplasma gondii | selenide, water dikinase | 0.0019 | 0.0099 | 0.0329 |
Plasmodium falciparum | type II NADH:ubiquinone oxidoreductase | 0.0019 | 0.0099 | 0.0329 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.007 | 0.0913 | 0.304 |
Leishmania major | dihydrolipoamide dehydrogenase, putative | 0.007 | 0.0913 | 0.304 |
Leishmania major | trypanothione reductase | 0.0203 | 0.3002 | 1 |
Mycobacterium ulcerans | dehydrogenase | 0.0017 | 0.007 | 0.0762 |
Echinococcus multilocularis | lysine specific histone demethylase 1A | 0.0083 | 0.1108 | 0.354 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.004 | 0.0434 | 0.1445 |
Leishmania major | 2,4-dienoyl-coa reductase fadh1, putative | 0.0019 | 0.0099 | 0.0329 |
Mycobacterium ulcerans | NADH dehydrogenase Ndh1 | 0.0019 | 0.0099 | 0.1083 |
Trypanosoma brucei | flap endonuclease-1 (FEN-1), putative | 0.0029 | 0.0257 | 0.0856 |
Leishmania major | UDP-galactopyranose mutase | 0.0017 | 0.007 | 0.0232 |
Plasmodium falciparum | ferrodoxin reductase-like protein | 0.0019 | 0.0099 | 0.0329 |
Echinococcus multilocularis | flap endonuclease 1 | 0.0029 | 0.0257 | 0.0639 |
Mycobacterium tuberculosis | Probable soluble pyridine nucleotide transhydrogenase SthA (STH) (NAD(P)(+) transhydrogenase [B-specific]) (nicotinamide nucleot | 0.007 | 0.0913 | 0.1075 |
Mycobacterium ulcerans | dehydrogenase | 0.0019 | 0.0099 | 0.1083 |
Schistosoma mansoni | glutamate synthase | 0.0019 | 0.0099 | 0.0099 |
Schistosoma mansoni | glutamate synthase | 0.0019 | 0.0099 | 0.0099 |
Mycobacterium tuberculosis | Probable membrane NADH dehydrogenase NdhA | 0.0464 | 0.7097 | 0.8962 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.004 | 0.0434 | 0.1445 |
Loa Loa (eye worm) | pyridine nucleotide-disufhide oxidoreductase | 0.0019 | 0.0099 | 0.0245 |
Schistosoma mansoni | flap endonuclease-1 | 0.0026 | 0.0213 | 0.0213 |
Trypanosoma cruzi | NADH dehydrogenase, putative | 0.0019 | 0.0099 | 0.0329 |
Brugia malayi | ImpB/MucB/SamB family protein | 0.004 | 0.0434 | 0.1074 |
Echinococcus multilocularis | dihydrolipoamide dehydrogenase | 0.007 | 0.0913 | 0.2875 |
Onchocerca volvulus | 0.009 | 0.1218 | 1 | |
Echinococcus granulosus | TGF beta signal transducer SmadC | 0.0018 | 0.0093 | 0.0081 |
Trypanosoma brucei | unspecified product | 0.004 | 0.0434 | 0.1445 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.004 | 0.0434 | 0.1445 |
Mycobacterium ulcerans | protoporphyrinogen oxidase | 0.0017 | 0.007 | 0.0762 |
Echinococcus multilocularis | dihydropyrimidine dehydrogenase (NADP+) | 0.0019 | 0.0099 | 0.01 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.004 | 0.0434 | 0.1445 |
Plasmodium falciparum | thioredoxin reductase | 0.007 | 0.0913 | 0.304 |
Echinococcus multilocularis | NADPH:adrenodoxin oxidoreductase | 0.0019 | 0.0099 | 0.01 |
Trypanosoma brucei | pyridine nucleotide-disulphide oxidoreductase, putative | 0.0019 | 0.0099 | 0.0329 |
Mycobacterium tuberculosis | NADPH:adrenodoxin oxidoreductase FprA (NADPH-ferredoxin reductase) | 0.0019 | 0.0099 | 0.0037 |
Plasmodium vivax | ferrodoxin reductase, putative | 0.0019 | 0.0099 | 0.0329 |
Schistosoma mansoni | amine oxidase | 0.0017 | 0.007 | 0.007 |
Loa Loa (eye worm) | hypothetical protein | 0.0017 | 0.007 | 0.0172 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0018 | 0.0093 | 0.0231 |
Trichomonas vaginalis | glutathione reductase, putative | 0.007 | 0.0913 | 1 |
Brugia malayi | Pyridine nucleotide-disulphide oxidoreductase family protein | 0.0019 | 0.0099 | 0.0245 |
Mycobacterium leprae | PROBABLE NADPH:ADRENODOXIN OXIDOREDUCTASE FPRB (ADRENODOXIN REDUCTASE) (AR) (FERREDOXIN-NADP(+) REDUCTASE) | 0.0019 | 0.0099 | 0.0037 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.007 | 0.0913 | 0.304 |
Leishmania major | acetoin dehydrogenase e3 component-like protein | 0.007 | 0.0913 | 0.304 |
Echinococcus granulosus | dna polymerase eta | 0.004 | 0.0434 | 0.1242 |
Mycobacterium ulcerans | hypothetical protein | 0.0019 | 0.0099 | 0.1083 |
Trypanosoma brucei | unspecified product | 0.0028 | 0.0239 | 0.0795 |
Plasmodium vivax | hypothetical protein, conserved | 0.0017 | 0.007 | 0.0232 |
Toxoplasma gondii | non-proton pumping type-II NADH dehydrogenase I | 0.0019 | 0.0099 | 0.0329 |
Mycobacterium ulcerans | ferredoxin reductase | 0.0019 | 0.0099 | 0.1083 |
Loa Loa (eye worm) | hypothetical protein | 0.004 | 0.0434 | 0.1074 |
Echinococcus multilocularis | sulfide:quinone oxidoreductase | 0.0019 | 0.0099 | 0.01 |
Mycobacterium tuberculosis | Probable NADH-dependent glutamate synthase (small subunit) GltD (L-glutamate synthase) (L-glutamate synthetase) (NADH-glutamate | 0.0019 | 0.0099 | 0.0037 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.007 | 0.0913 | 0.304 |
Mycobacterium tuberculosis | NAD(P)H quinone reductase LpdA | 0.0515 | 0.7911 | 1 |
Echinococcus multilocularis | apoptosis inducing factor 1 mitochondrial | 0.0019 | 0.0099 | 0.01 |
Mycobacterium ulcerans | dihydrolipoamide dehydrogenase, LpdB | 0.007 | 0.0913 | 1 |
Loa Loa (eye worm) | glutathione reductase | 0.0203 | 0.3002 | 0.7435 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0028 | 0.0239 | 0.0795 |
Mycobacterium ulcerans | monoxygenase | 0.0019 | 0.0099 | 0.1083 |
Echinococcus granulosus | sulfide:quinone oxidoreductase | 0.0019 | 0.0099 | 0.01 |
Mycobacterium ulcerans | glutamate synthase subunit beta | 0.0019 | 0.0099 | 0.1083 |
Leishmania major | 2-oxoglutarate dehydrogenase, e3 component, lipoamidedehydrogenase-like protein | 0.007 | 0.0913 | 0.304 |
Trypanosoma cruzi | UDP-galactopyranose mutase | 0.0017 | 0.007 | 0.0232 |
Plasmodium falciparum | NAD(P)H-dependent glutamate synthase, putative | 0.0019 | 0.0099 | 0.0329 |
Plasmodium falciparum | protoporphyrinogen oxidase | 0.0017 | 0.007 | 0.0232 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0019 | 0.0099 | 0.0329 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.004 | 0.0434 | 0.1445 |
Trypanosoma cruzi | pyridine nucleotide-disulphide oxidoreductase, putative | 0.0019 | 0.0099 | 0.0329 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0269 | 0.4037 | 1 |
Mycobacterium ulcerans | NADPH dependent 2,4-dienoyl-CoA reductase FadH | 0.0019 | 0.0099 | 0.1083 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0099 | 0.0245 |
Leishmania major | hypothetical protein, conserved | 0.0019 | 0.0099 | 0.0329 |
Schistosoma mansoni | smad | 0.0018 | 0.0093 | 0.0093 |
Treponema pallidum | NADH oxidase | 0.007 | 0.0913 | 1 |
Trypanosoma cruzi | NADH dehydrogenase, putative | 0.0019 | 0.0099 | 0.0329 |
Brugia malayi | dihydrolipoyl dehydrogenase, mitochondrial precursor, putative | 0.007 | 0.0913 | 0.226 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.004 | 0.0434 | 0.1445 |
Schistosoma mansoni | Smad4 | 0.0018 | 0.0093 | 0.0093 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.007 | 0.0913 | 0.304 |
Trichomonas vaginalis | flap endonuclease-1, putative | 0.0029 | 0.0257 | 0.1941 |
Chlamydia trachomatis | dihydrolipoyl dehydrogenase | 0.007 | 0.0913 | 1 |
Plasmodium vivax | thioredoxin reductase, putative | 0.0203 | 0.3002 | 1 |
Schistosoma mansoni | Protoporphyrinogen oxidase chloroplast/mitochondrial precursor | 0.0017 | 0.007 | 0.007 |
Loa Loa (eye worm) | thioredoxin reductase | 0.0203 | 0.3002 | 0.7435 |
Mycobacterium ulcerans | NADH dehydrogenase | 0.0019 | 0.0099 | 0.1083 |
Echinococcus multilocularis | dna polymerase eta | 0.004 | 0.0434 | 0.1242 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0019 | 0.0099 | 0.0329 |
Mycobacterium ulcerans | monoamine oxidase | 0.0017 | 0.007 | 0.0762 |
Mycobacterium ulcerans | dihydrolipoamide dehydrogenase | 0.007 | 0.0913 | 1 |
Wolbachia endosymbiont of Brugia malayi | dihydrolipoamide dehydrogenase E3 component | 0.007 | 0.0913 | 1 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.007 | 0.0913 | 0.304 |
Toxoplasma gondii | thioredoxin reductase | 0.0203 | 0.3002 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.004 | 0.0434 | 0.1445 |
Trypanosoma brucei | dihydrolipoyl dehydrogenase | 0.007 | 0.0913 | 0.304 |
Brugia malayi | Flap endonuclease-1 | 0.0029 | 0.0257 | 0.0636 |
Plasmodium falciparum | glutathione reductase | 0.0203 | 0.3002 | 1 |
Trypanosoma cruzi | UDP-galactopyranose mutase | 0.0017 | 0.007 | 0.0232 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0028 | 0.0239 | 0.0795 |
Entamoeba histolytica | deoxycytidyl transferase, putative | 0.004 | 0.0434 | 1 |
Plasmodium vivax | glutathione reductase, putative | 0.0203 | 0.3002 | 1 |
Trypanosoma brucei | dihydrolipoamide dehydrogenase, point mutation | 0.007 | 0.0913 | 0.304 |
Plasmodium vivax | hypothetical protein, conserved | 0.0017 | 0.007 | 0.0232 |
Mycobacterium tuberculosis | Probable nitrite reductase [NAD(P)H] large subunit [FAD flavoprotein] NirB | 0.0464 | 0.7097 | 0.8962 |
Echinococcus granulosus | dihydropyrimidine dehydrogenase NADP | 0.0019 | 0.0099 | 0.01 |
Echinococcus multilocularis | glutamate synthase | 0.0019 | 0.0099 | 0.01 |
Trypanosoma cruzi | pyridine nucleotide-disulphide oxidoreductase, putative | 0.0019 | 0.0099 | 0.0329 |
Trypanosoma brucei | pyridine nucleotide-disulphide oxidoreductase, putative | 0.0019 | 0.0099 | 0.0329 |
Schistosoma mansoni | sulfide quinone reductase | 0.0019 | 0.0099 | 0.0099 |
Schistosoma mansoni | amine oxidase | 0.0017 | 0.007 | 0.007 |
Leishmania major | 2,4-dienoyl-coa reductase-like protein | 0.0019 | 0.0099 | 0.0329 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.004 | 0.0434 | 0.1445 |
Brugia malayi | SWIRM domain containing protein | 0.009 | 0.1218 | 0.3016 |
Mycobacterium tuberculosis | NADPH-dependent mycothiol reductase Mtr | 0.0203 | 0.3002 | 0.3739 |
Loa Loa (eye worm) | ImpB/MucB/SamB family protein | 0.004 | 0.0434 | 0.1074 |
Mycobacterium tuberculosis | Putative ferredoxin reductase | 0.0464 | 0.7097 | 0.8962 |
Schistosoma mansoni | smad1 5 8 and | 0.0018 | 0.0093 | 0.0093 |
Echinococcus granulosus | glutamate synthase | 0.0019 | 0.0099 | 0.01 |
Leishmania major | hypothetical protein, conserved | 0.0019 | 0.0099 | 0.0329 |
Schistosoma mansoni | smad1 5 8 and | 0.0018 | 0.0093 | 0.0093 |
Wolbachia endosymbiont of Brugia malayi | dihydrolipoamide dehydrogenase E3 component | 0.007 | 0.0913 | 1 |
Mycobacterium tuberculosis | Probable oxidoreductase | 0.0515 | 0.7911 | 1 |
Plasmodium falciparum | dihydrolipoyl dehydrogenase, apicoplast | 0.007 | 0.0913 | 0.304 |
Toxoplasma gondii | flap structure-specific endonuclease 1, putative | 0.0029 | 0.0257 | 0.0856 |
Echinococcus granulosus | pyridine nucleotide disulfide oxidoreductase | 0.0019 | 0.0099 | 0.01 |
Loa Loa (eye worm) | hypothetical protein | 0.0083 | 0.1108 | 0.2743 |
Leishmania major | DNA polymerase kappa, putative | 0.004 | 0.0434 | 0.1445 |
Chlamydia trachomatis | thioredoxin reductase | 0.0019 | 0.0099 | 0.0348 |
Mycobacterium ulcerans | flavin-containing monoamine oxidase AofH | 0.0017 | 0.007 | 0.0762 |
Plasmodium falciparum | flap endonuclease 1 | 0.0029 | 0.0257 | 0.0856 |
Leishmania major | DNA polymerase eta, putative | 0.004 | 0.0434 | 0.1445 |
Giardia lamblia | Glycerol-3-phosphate dehydrogenase | 0.0019 | 0.0099 | 0.1083 |
Loa Loa (eye worm) | MH1 domain-containing protein | 0.0018 | 0.0093 | 0.0231 |
Mycobacterium tuberculosis | Possible DNA-damage-inducible protein P DinP (DNA polymerase V) (pol IV 2) (DNA nucleotidyltransferase (DNA-directed)) | 0.004 | 0.0434 | 0.0464 |
Leishmania major | dihydrolipoamide dehydrogenase, putative | 0.007 | 0.0913 | 0.304 |
Trypanosoma cruzi | DNA polymerase eta, putative | 0.004 | 0.0434 | 0.1445 |
Giardia lamblia | Flap structure-specific endonuclease | 0.0029 | 0.0257 | 0.2814 |
Giardia lamblia | NADH oxidase lateral transfer candidate | 0.007 | 0.0913 | 1 |
Brugia malayi | Pyridine nucleotide-disulphide oxidoreductase, dimerisation domain containing protein | 0.0052 | 0.0619 | 0.1532 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0269 | 0.4037 | 1 |
Plasmodium vivax | type II NADH:ubiquinone oxidoreductase, putative | 0.0019 | 0.0099 | 0.0329 |
Trypanosoma cruzi | NADPH:adrenodoxin oxidoreductase, mitochondrial, putative | 0.0019 | 0.0099 | 0.0329 |
Entamoeba histolytica | Flap nuclease, putative | 0.0029 | 0.0257 | 0.4717 |
Toxoplasma gondii | histone lysine-specific demethylase | 0.0017 | 0.007 | 0.0232 |
Mycobacterium tuberculosis | Probable NADPH:adrenodoxin oxidoreductase FprB (adrenodoxin reductase) (AR) (ferredoxin-NADP(+) reductase) | 0.0019 | 0.0099 | 0.0037 |
Mycobacterium ulcerans | flavin-containing monoamine oxidase AofH | 0.0017 | 0.007 | 0.0762 |
Brugia malayi | MH1 domain containing protein | 0.0018 | 0.0093 | 0.0231 |
Schistosoma mansoni | smad1 5 8 and | 0.0018 | 0.0093 | 0.0093 |
Plasmodium vivax | NAD(P)H-dependent glutamate synthase, putative | 0.0019 | 0.0099 | 0.0329 |
Trypanosoma cruzi | trypanothione reductase, putative | 0.007 | 0.0913 | 0.304 |
Echinococcus multilocularis | pyridine nucleotide disulfide oxidoreductase | 0.0019 | 0.0099 | 0.01 |
Toxoplasma gondii | pyridine nucleotide-disulfide oxidoreductase domain-containing protein | 0.0019 | 0.0099 | 0.0329 |
Echinococcus granulosus | mothers against decapentaplegic 5 | 0.0018 | 0.0093 | 0.0081 |
Brugia malayi | amine oxidase, flavin-containing family protein | 0.0024 | 0.018 | 0.0445 |
Schistosoma mansoni | Lysine-specific histone demethylase 1 | 0.0083 | 0.1108 | 0.1108 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0028 | 0.0239 | 0.0795 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.004 | 0.0434 | 0.1445 |
Echinococcus multilocularis | thioredoxin glutathione reductase | 0.0203 | 0.3002 | 1 |
Brugia malayi | Pyridine nucleotide-disulphide oxidoreductase family protein | 0.0019 | 0.0099 | 0.0245 |
Toxoplasma gondii | NADPH-glutathione reductase | 0.007 | 0.0913 | 0.304 |
Plasmodium vivax | dihydrolipoyl dehydrogenase, apicoplast, putative | 0.007 | 0.0913 | 0.304 |
Echinococcus granulosus | terminal deoxycytidyl transferase rev1 | 0.004 | 0.0434 | 0.1242 |
Schistosoma mansoni | DNA polymerase eta | 0.004 | 0.0434 | 0.0434 |
Schistosoma mansoni | hypothetical protein | 0.0019 | 0.0099 | 0.0099 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | > 100 uM | Inhibition of [3H]-L-689,560 binding to Glycine site of NMDA receptor of rat cortical membranes | ChEMBL. | No reference |
IC50 (binding) | > 100 uM | Inhibition of [3H]-L-689,560 binding to Glycine site of NMDA receptor of rat cortical membranes | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.